Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -41.79x as of the fiscal period ended Tuesday, December 31, 2013.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-41.79x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-3.05x
median of 295 covered companies
CURRENT VS SECTOR MEDIAN
-1270.08%
vs the sector median at left
aTyr Pharma, Inc.
Market Cap
$28.43M
Interest Coverage Ratio
-41.79x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$27.31M
Interest Coverage Ratio
-14.43x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30.65M
Interest Coverage Ratio
N/A
TTM Avg
1.23x
3Y Avg
1.23x
5Y Avg
1.23x
Market Cap
$30.92M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.36M
Interest Coverage Ratio
-34.63x
TTM Avg
34.14x
3Y Avg
47.81x
5Y Avg
52.62x
Market Cap
$25.48M
Interest Coverage Ratio
-17.20x
TTM Avg
55.75x
3Y Avg
55.75x
5Y Avg
55.75x
Market Cap
$32.31M
Interest Coverage Ratio
-10.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.44M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| aTyr Pharma, Inc. (ATYR) | $28.43M | -41.79x | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | -14.43x | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.65M | N/A | 1.23x | 1.23x | 1.23x |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -34.63x | 34.14x | 47.81x | 52.62x |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -17.20x | 55.75x | 55.75x | 55.75x |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | -10.67x | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | N/A | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | N/A | N/A | N/A | N/A |
Interest Coverage
-41.8x
Debt/Equity
0.23
Current Ratio
5.12
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2013-12-31 | -41.79x |
